← Back to Insights
November 6, 2024
Authors
David Burda
Topics
Economics Outcomes System Dynamics
Channels
Blogs

It’s Big Pharma’s Turn to Point the Finger

It’s time for another installment of my healthcare blame game series. The series is based on my theory that sectors of the healthcare industry take turns blaming each other for high costs, limited access and poor quality while tacitly agreeing amongst themselves not to really do anything about it.

This segment is brought to you by Big Pharma, which is blaming primarily health insurers, and to a lesser extent providers, for consumer access problems.

The blame is embodied in a report called Access Denied: Patients Speak Out on Insurance Barriers and the Need for Policy Change. The 28-page report is based on a survey of about 2,600 U.S. adults age 18 or older conducted by Ipsos (the market research firm) for Pharmaceutical Research and Manufacturers of America (PhRMA), the trade group representing drug companies.

I cherry-picked some of the “shocking” survey results that support my theory.

  • 41% of the respondents said they experienced one or more barriers to accessing medications prescribed by their physicians, including prior authorization requirements and their prescribed drugs not being in their health plan’s drug formulary.
  • 51% of the respondents said they can’t anticipate what they’ll pay for their prescription drugs even if they’re covered by their health plan.
  • 70% of the respondents said they strongly support requiring hospitals and clinics to publicly disclose how much they mark up the prices that they charge for prescription medication. (If you know any adult not in healthcare who knows providers mark up prices for drugs, let me know.)
  • 59% and 54% of the respondents, respectively, said they have unpaid hospital bills and doctors’ bills. (Only 9% said they have unpaid drug bills.)
  • 32% of the respondents cited out-of-pocket costs not covered by their health plan as their most important healthcare issue. (Only 16% cited the cost of prescription drugs as their top issue.)
  • 80% of the respondents cited reducing inefficiency and bureaucracy in the health system as the best way elected officials can help patients. (Regulating drug prices was not on the list of choices published in the report.)
  • 97% of the respondents with at least one chronic disease “strongly” or “somewhat” agreed that it’s important to have access to medicines that prevent illness, in addition to those that treat or cure diseases. (Who are the 3% that disagreed with that statement?)

Of course, a lot of the healthcare trade press picked up the story and covered it as news rather than the industry propaganda that it is. The tell is the question the survey asked about whether hospitals should be transparent about how they spend savings from the 340B drug discount program. Like drug mark-ups by providers, your average consumer doesn’t know anything about them unless prompted by a leading survey question from a drug company trade association.

I’ll check that with my mom the next time I’m over. “Mom, these peanut butter cookies are great. Just a little burnt like I like them. What do you think about how hospitals spend their 340B program savings?”

Thanks for reading.

To learn more about this topic, please read:

About the Author

David Burda

David Burda began covering healthcare in 1983 and hasn’t stopped since. Dave writes this monthly column “Burda on Healthcare,” contributes weekly blog posts, manages our weekly newsletter 4sight Friday, and hosts our weekly Roundup podcast. Dave believes that healthcare is a business like any other business, and customers — patients — are king. If you do what’s right for patients, good business results will follow.

Dave’s personnel experiences with the healthcare system both as a patient and family caregiver have shaped his point of view. It’s also been shaped by covering the industry for 40 years as a reporter and editor. He worked at Modern Healthcare for 25 years, the last 11 as editor.

Prior to Modern Healthcare, he did stints at the American Medical Record Association (now AHIMA) and the American Hospital Association. After Modern Healthcare, he wrote a monthly column for Twin Cities Business explaining healthcare trends to a business audience, and he developed and executed content marketing plans for leading healthcare corporations as the editorial director for healthcare strategies at MSP Communications.

When he’s not reading and writing about healthcare, Dave spends his time riding the trails of DuPage County, IL, on his bike, tending his vegetable garden and daydreaming about being a lobster fisherman in Maine. He lives in Wheaton, IL, with his lovely wife of 40 years and his three children, none of whom want to be journalists or lobster fishermen.

Recent Posts

System Dynamics
AMA Says Insurers Are Using Their Market Power to Screw Patients and Providers
When I started this Healthcare Blame Game series I didn’t think the rounds would pop up on a… Read More
By November 27, 2024
Economics
Podcast: How Healthcare Revolutionaries Think With Hal Andrews
Podcast: Hal Andrews on the Biggest Trends Reshaping the Healthcare Economy President and CEO of Trilliant Health Hal… Read More
By November 26, 2024
Economics
AMA Draws Blood With Policy on Hospital Tax Exemptions
There are certain lines you don’t cross, even when you point the finger at another healthcare industry sector… Read More
By November 20, 2024